Ceftolozane News
Ceftolozane currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Ceftolozane with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: See EMA product information
- Evidence level: L5
- Predicted indications (20):
- urinary tract infection (disease) (99.9%)
- gonococcal urethritis (99.9%)
- Ureaplasma urethritis (99.9%)
- uterine inflammatory disease (99.9%)
- xanthogranulomatous pyelonephritis (99.9%)
- hyperamylasemia (99.5%)
- polyclonal hyperviscosity syndrome (99.5%)
- urogenital tuberculosis (99.5%)
- congenital analbuminemia (99.4%)
- blood group incompatibility (99.2%)
- premalignant hematological system disease (99.1%)
- monoclonal gammopathy (99.1%)
- hematological disease associated with an acquired peripheral neuropathy (99.0%)
- congenital hematological disorder (98.6%)
- septicemic plague (98.5%)
- epiglottitis (98.1%)
- hematopoietic and lymphoid system neoplasm (97.6%)
- pyelitis (96.4%)
- laryngitis (96.4%)
- abdominal tuberculosis (95.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.